Cargando…
Frailty in randomised controlled trials for dementia or mild cognitive impairment measured via the frailty index: prevalence and prediction of serious adverse events and attrition
BACKGROUND: Frailty and dementia have a bidirectional relationship. However, frailty is rarely reported in clinical trials for dementia and mild cognitive impairment (MCI) which limits assessment of trial applicability. This study aimed to use a frailty index (FI)—a cumulative deficit model of frail...
Autores principales: | Wightman, Heather, Quinn, Terry J., Mair, Frances S., Lewsey, Jim, McAllister, David A., Hanlon, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262528/ https://www.ncbi.nlm.nih.gov/pubmed/37312157 http://dx.doi.org/10.1186/s13195-023-01260-3 |
Ejemplares similares
-
Systematic review and meta-analysis of prevalence, trajectories, and clinical outcomes for frailty in COPD
por: Hanlon, Peter, et al.
Publicado: (2023) -
Prevalence, measurement, and implications of frailty in stroke survivors: An analysis of three global aging cohorts
por: Hanlon, Peter, et al.
Publicado: (2023) -
Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions
por: Hanlon, Peter, et al.
Publicado: (2020) -
Frailty in people with rheumatoid arthritis: a systematic review of observational studies
por: Hanlon, Peter, et al.
Publicado: (2022) -
Identification and prevalence of frailty in diabetes mellitus and association with clinical outcomes: a systematic review protocol
por: Hanlon, Peter, et al.
Publicado: (2020)